Evaluation of Intravenous Dalbavancin for Peritonitis

Daptomycin + Meropenem Versus Ceftazidime in the Treatment of Nosocomial Spontaneous Bacterial Peritonitis

NCT01455246 ·Status: TERMINATED ·Phase: PHASE2/PHASE3

Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis

NCT03310606 ·Status: UNKNOWN ·Phase: NA

Pilot Trial of Antibiotics Versus Surgery for Treating Acute Appendicitis

NCT02447224 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Study Comparing the Safety and Efficacy of Intravenous CXA-201 and Intravenous Levofloxacin in Complicated Urinary Tract Infection, Including Pyelonephritis

NCT01345929 ·Status: COMPLETED ·Phase: PHASE3

Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood

NCT02482051 ·Status: COMPLETED

EXTENDed Antibiotic Durations Compared to Standard Durations for Patients With Complicated Intra-abdominal Infection.

NCT05148702 ·Status: RECRUITING ·Phase: PHASE3

Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae

NCT02420366 ·Status: COMPLETED

Study Evaluating the Etiology of Intra-Abdominal Infections

NCT00244088 ·Status: COMPLETED

Negative Predictive Value of Drug Provocation Tests to Beta-lactams

NCT02844712 ·Status: TERMINATED ·Phase: NA

Identification of Ascitic Fluid Bacterial Pathogens in Spontaneous Bacterial Peritonitis

NCT02463721 ·Status: UNKNOWN ·Phase: NA

Impact of Rapid Molecular Diagnostic Method on Antibiotics Exposure Duration in ICU Patients with Postoperative Peritonitis

NCT04925388 ·Status: TERMINATED ·Phase: NA

Duration of Antibiotic Therapy in the Treatment of Severe Postoperative Peritonitis Admitted in ICU

NCT01311765 ·Status: COMPLETED ·Phase: PHASE3

Xydalba Utilization Registry in Germany

NCT03696901 ·Status: TERMINATED

Reporting Patterns and Results of Initial Antibiotic Treatment in Patients With cUTI, cIAI,NP Including VAP

NCT02364284 ·Status: COMPLETED

Is Spontaneous Bacterial Peritonitis Still Responding to 3rd Generation Cephalosporins?

NCT02443285 ·Status: UNKNOWN ·Phase: PHASE3

Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases

NCT02127450 ·Status: COMPLETED

Study to Evaluate the Duration of Treatment With Ertapenem in Acute Attacks of Sigmoid Diverticulitis

NCT00097734 ·Status: UNKNOWN ·Phase: PHASE4

Diagnosis of Spontaneous Bacterial Peritonitis

NCT01598870 ·Status: UNKNOWN

Rifaximin Versus Norfloxacin in Spontaneous Bacterial Peritonitis

NCT04159870 ·Status: UNKNOWN ·Phase: PHASE3

Emergence of Resistance in Intestinal Microflora During Carbapenem Treatments

NCT01703299 ·Status: COMPLETED

BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU

NCT03147807 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

NCT00157898 ·Status: COMPLETED ·Phase: PHASE4

GSK2251052 in the Treatment of Complicated Intra-abdominal Infections

NCT01381562 ·Status: TERMINATED ·Phase: PHASE2

Carbapenem Antibiotic Therapy for VIM Carbapenemase-Producing Enterobacteriaceae Infections

NCT06185153 ·Status: RECRUITING

Efficacy and Safety Study of Eravacycline Compared With Ertapenem in Complicated Intra-abdominal Infections

NCT01844856 ·Status: COMPLETED ·Phase: PHASE3